Time to buy IT and pharma stocks
IT sector's trading multiples hit post-Lehman lows, providing good entry points Since February 26,...
Read moreIFC to lend $147 mn to Jubilant Pharma
IFC, a member of the World Bank Group, is lending $147.5 million (around Rs 866 crore) to Jubilant...
Read moreAstraZeneca shares fall after Pfizer walks away from deal
Pfizer concedes defeat after £55 a share offer was rejected last week by the AstraZeneca...
Read moreDrugmaker Pfizer Abandons $118B Bid for British Pharma Giant
Pharmaceutical giant Pfizer has abandoned its current attempt to buy AstraZeneca for nearly $118...
Read morePharma's iPad love affair continues
It's no secret that pharmaceutical companies have long been enamoured with Apple's iPad, but the...
Read morePharma firm gets FDA notice
Drug authority issues notices to Wockhardt’s three plants in Aurangabad and seeks explanation on...
Read moreChemists find help from nature in fighting cancer
Inspired by a chemical that fungi secrete to defend their territory, MIT chemists have synthesized...
Read moreDigital Health: Will Pharma Follow or Lead?
Time to step up or step out of the way? The digital health movement is growing rapidly.
Read moreDrugmakers And NIH Band Together To Speed Up Research
The National Institutes of Health is teaming up with major drug companies in a new effort to...
Read moreSamsung Invests in Drugs After Outselling Apple’s IPhone
Samsung (005930) Group transformed its electronics unit into the world’s largest smartphone maker...
Read more



